2 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Tracey McLaughlin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia Lyo avexitide, Liq avexitide - Post Bariatric Hypoglycemia | Phase 2 | Completed | Tracey McLaughlin | 19 | 2016-05-01 | 2020-11-13 |
| Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia Exendin (9-39) - Hyperinsulinemia Hypoglycemia | Phase 1 | Completed | Tracey McLaughlin | 9 | 2015-04-01 | 2024-12-04 |
| Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery Exendin (9-39), Placebo - Hypoglycemia | Phase 1 | Terminated | Tracey McLaughlin | 10 | 2014-02-01 | 2024-12-04 |
Congenital Hyperinsulinism (1) · Glucose Metabolism Disorders (1) · Hypoglycemia (1)
exendin (9-39) (3)
United States (3)
Colleen Craig, M.D. (1) · Marilyn Tan, MD (1)